Thus, we further validated the predictive role of FEP score in response to ICIs in an anti-PD-L1 cohort (IMvigor210) in urinary carcinoma instead because of the lack of cohorts treated with immunotherapy in NPC. This evidence concerns the gene CD274 and nasopharyngeal carcinoma.